Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dewi Guellec

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
Arthritis & Rheumatology (Hoboken, N.J.)|May 8, 2025
Maintenance of remission after tocilizumab withdrawal in patients with glucocorticoid-dependent polymyalgia rheumaticaBaptiste Chevet, Aghiles Souki, Emmanuel Nowak, et al.
Rheumatology (Oxford, England)|December 19, 2024
Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional studyAlice Tison, Sandrine Jousse-Joulin, Maëlys Consigny, et al.
NEJM Evidence|February 6, 2024
Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical PatientsDominique Mottier, Philippe Girard, Francis Couturaud, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
Arthritis & Rheumatology (Hoboken, N.J.)|May 8, 2025
Maintenance of remission after tocilizumab withdrawal in patients with glucocorticoid-dependent polymyalgia rheumaticaBaptiste Chevet, Aghiles Souki, Emmanuel Nowak, et al.
Rheumatology (Oxford, England)|December 19, 2024
Are ultrasound salivary parenchymal lesions more severe in primary Sjögren patients with a longer disease duration? A cross-sectional studyAlice Tison, Sandrine Jousse-Joulin, Maëlys Consigny, et al.
NEJM Evidence|February 6, 2024
Enoxaparin versus Placebo to Prevent Symptomatic Venous Thromboembolism in Hospitalized Older Adult Medical PatientsDominique Mottier, Philippe Girard, Francis Couturaud, et al.
Pageof 6